28.01.2018 • News

EP Wants to Study Pesticide Approval Procedure

The European Parliament is planning to establish a special committee to review...
The European Parliament is planning to establish a special committee to review the EU’s authorization procedure for crop protection agents (c) Federico Rostagno/Shutterstock

The European Parliament is planning to establish a special committee to review the EU’s authorization procedure for crop protection agents.

The plans reflect the Parliament’s dissatisfaction with the outcome of the protracted re-authorization procedure for glyphosate, which in November 2017 resulted in the chemical‘s license being renewed for another five years.

A plenary session on Feb. 5-8 will make the final decision about establishing the committee, which is planned to have 30 members and a nine-month term. It will be tasked with delivering a final report of its factual findings and recommendations, which would be submitted to the full house for approval.

One of the new parliamentary body’s tasks would be to assess potential failures and conflicts of interest in the risk assessment and approval procedure as well as inadequacies in the way substances are scientifically evaluated and approved. The committee is expected to also examine the role of the European Commission in renewing the glyphosate license.

Additionally, the MEPs plan to evaluate the role of EU agencies in the approval procedure to determine whether they are adequately staffed and financed.

In a resolution passed in October 2017, the EP said the so-called “Monsanto Papers,” internal documents from the US chemical giant, which produces the glyphosate-based herbicide Roundup, “shed doubt on the credibility of some studies used in the EU evaluation on glyphosate safety.”

The EU should only consider published, peer-reviewed and independent studies commissioned by competent public authorities, the Parliament said. In the review of glyphosate, some reports suggested that European safety agencies may have relied in part on Monsanto studies when drawing conclusions on glyphosate’s safety.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.